Literature DB >> 28510151

CFTR structure and function: is there a role in the kidney?

J Souza-Menezes1, M M Morales2,3.   

Abstract

Cystic fibrosis (CF) is a lethal autosomal recessive genetic disease caused by mutations in the CF transmembrane conductance regulator (CFTR). Mutations in the CFTR gene may result in a defective protein processing that leads to changes in function and regulation of this chloride channel. Despite of the expression of CFTR in the kidney, patients with CF do not present major renal dysfunction, but it is known that both the urinary excretion of proteins and renal capacity to concentrate and dilute urine are altered in these patients. CFTR mRNA is expressed in all nephron segments of rat and human, and this abundance is more prominent in renal cortex and outer medulla renal areas. CFTR protein was detected in apical surface of both proximal and distal tubules of rat kidney but not in the outer medullary collecting ducts. Studies have demonstrated that CFTR does not only transport Cl- but also ATP. ATP transport by CFTR could be involved in the control of other ion transporters such as Na+ (ENaC) and K+ (renal outer medullary potassium) channels, especially in TAL and CCD. In the kidney, CFTR also might be involved in the endocytosis of low-molecular-weight proteins by proximal tubules. This review is focused on the CFTR function and structure, its role in the renal physiology, and its modulation by hormones involved in the control of extracellular fluid volume.

Entities:  

Keywords:  CFTR; Chloride channel; ENaC; Kidney; Nephron; ROMK; TNR-CFTR

Year:  2009        PMID: 28510151      PMCID: PMC5387792          DOI: 10.1007/s12551-008-0002-3

Source DB:  PubMed          Journal:  Biophys Rev        ISSN: 1867-2450


  94 in total

1.  Nucleotides regulate NaCl transport in mIMCD-K2 cells via P2X and P2Y purinergic receptors.

Authors:  D E McCoy; A L Taylor; B A Kudlow; K Karlson; M J Slattery; L M Schwiebert; E M Schwiebert; B A Stanton
Journal:  Am J Physiol       Date:  1999-10

2.  Effect of luminal nucleotides on Cl- secretion and Na+ absorption in distal bronchi.

Authors:  S K Inglis; A Collett; H L McAlroy; S M Wilson; R E Olver
Journal:  Pflugers Arch       Date:  1999-10       Impact factor: 3.657

Review 3.  Renal potassium transport: mechanisms and regulation.

Authors:  G Giebisch
Journal:  Am J Physiol       Date:  1998-05

Review 4.  Thyroid hormone and the kidney.

Authors:  A I Katz; D S Emmanouel; M D Lindheimer
Journal:  Nephron       Date:  1975       Impact factor: 2.847

Review 5.  Control of NaCl transport in the thick ascending limb.

Authors:  S C Hebert; T E Andreoli
Journal:  Am J Physiol       Date:  1984-06

6.  Both the wild type and a functional isoform of CFTR are expressed in kidney.

Authors:  M M Morales; T P Carroll; T Morita; E M Schwiebert; O Devuyst; P D Wilson; A G Lopes; B A Stanton; H C Dietz; G R Cutting; W B Guggino
Journal:  Am J Physiol       Date:  1996-06

7.  The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.

Authors:  Luba Aleksandrov; Andrei A Aleksandrov; Xiu-Bao Chang; John R Riordan
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

8.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.

Authors:  M Mall; M Bleich; R Greger; R Schreiber; K Kunzelmann
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 10.  Intracellular CFTR: localization and function.

Authors:  N A Bradbury
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

View more
  3 in total

Review 1.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 2.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.

Authors:  Andrew Burke; Daniel Smith; Chris Coulter; Scott C Bell; Rachel Thomson; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2021-05-13       Impact factor: 5.577

3.  Glibenclamide inhibits BK polyomavirus infection in kidney cells through CFTR blockade.

Authors:  Margarita-Maria Panou; Michelle Antoni; Ethan L Morgan; Eleni-Anna Loundras; Christopher W Wasson; Matthew Welberry-Smith; Jamel Mankouri; Andrew Macdonald
Journal:  Antiviral Res       Date:  2020-03-27       Impact factor: 5.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.